ENO2 and leukemia: The increase in the anticancer activity of Dx-PC-NSE complexes was accompanied by a significant decrease (p < 0.05) of superoxide production in Jurkat T-leukemia cells at early time points after treatment with various doses of Dx-PC-NSE, but not with Dx and Dx-PC.